Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Commissioner Kessler to answer FDA retaliation accusations at Nov. 15 House hearing.

This article was originally published in The Gray Sheet

Executive Summary

FDA COMMISSIONER KESSLER TO ADDRESS ALLEGATIONS OF AGENCY RETALIATION at a Nov. 15 hearing of Rep. Joe Barton's (R-Tex.) House Commerce/Oversight and Investigations Subcommittee. While a final witness list has not been compiled, Kessler is expected to be the lone witness at the session, although other agency officials are likely to attend, including Center for Devices and Radiological Health Director Bruce Burlington and Associate Commissioner for Regulatory Affairs Ronald Chesmore.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005005

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel